Zhongqiu Wang

Dec 29, 2023 | mdpi.com | Yuyan Li |Zheng Liu |Zhongqiu Wang |xun zhang

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Oct 18, 2023 | onlinelibrary.wiley.com | Yumiao Chen |Wei Li |Zhongqiu Wang |Yingying Yu

Immune cells are pivotal in cancer immunotherapy, yet their therapeutic effectiveness is often hampered by limited tumor infiltration and inhibitory tumor microenvironments. We here introduce an alkaline phosphatase (ALP)-responsive and transformable supramolecular bis-specific cell engager (Supra-BiCE) to harness NK/T cells for effective cancer immunotherapy.